AU2805397A - Vaginal application mifepristone - Google Patents

Vaginal application mifepristone

Info

Publication number
AU2805397A
AU2805397A AU28053/97A AU2805397A AU2805397A AU 2805397 A AU2805397 A AU 2805397A AU 28053/97 A AU28053/97 A AU 28053/97A AU 2805397 A AU2805397 A AU 2805397A AU 2805397 A AU2805397 A AU 2805397A
Authority
AU
Australia
Prior art keywords
mifepristone
vaginal application
vaginal
application
application mifepristone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28053/97A
Inventor
Horacio B. Croxatto-Avoni
Theodore M. Jackanicz
Alfred J. Moo-Young
Ana Maria Salvatierra Martinez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Population Council Inc
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Publication of AU2805397A publication Critical patent/AU2805397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU28053/97A 1996-08-30 1997-04-18 Vaginal application mifepristone Abandoned AU2805397A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2493296P 1996-08-30 1996-08-30
US60024932 1996-08-30
PCT/US1997/006570 WO1998008471A1 (en) 1996-08-30 1997-04-18 Vaginal application mifepristone

Publications (1)

Publication Number Publication Date
AU2805397A true AU2805397A (en) 1998-03-19

Family

ID=21823102

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28053/97A Abandoned AU2805397A (en) 1996-08-30 1997-04-18 Vaginal application mifepristone

Country Status (2)

Country Link
AU (1) AU2805397A (en)
WO (1) WO1998008471A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1987814A1 (en) 2007-04-30 2008-11-05 Exelgyn Mifepristone pharmaceutical compositions and their methods of preparation
TWI477276B (en) 2008-04-28 2015-03-21 Repros Therapeutics Inc Antiprogestin dosing regimens
JP5894143B2 (en) * 2010-03-22 2016-03-23 リプロス セラピューティクス インコーポレイテッド Compositions and methods for non-toxic delivery of antiprogestin
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
DE202011110356U1 (en) * 2011-03-10 2014-01-15 Arstat, Inc. Treatment of endometriosis by intravaginal administration of a low dose of a selective progesterone receptor modulator, an antigestagens or an antigestagen agent
ES2701400T3 (en) 2012-05-31 2019-02-22 Repros Therapeutics Inc Formulations for vaginal administration of antiprogestins
CA2888377C (en) 2012-11-02 2021-02-02 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468741A (en) * 1993-05-28 1995-11-21 The Regents Of The University Of California Use of low levels of mifepristone to treat leiomyomata

Also Published As

Publication number Publication date
WO1998008471A1 (en) 1998-03-05

Similar Documents

Publication Publication Date Title
AU2979795A (en) Tampon
AU1298499A (en) Vaginal sleeve
AU3304795A (en) Bisresorcinyltriazines
AU2832295A (en) Cytoanalyzer
AU3304995A (en) 2-Hydroxyphenyltriazines
AU3779295A (en) Crash attenuator
AU2837895A (en) Thiazine- or thiazepine-derivatives
AU4044795A (en) Handleset
AU3701397A (en) Anti-herpesviral agent
AU2308295A (en) Heterocyclylbenzonitriles
AUPM690494A0 (en) Attenuator
AU2805397A (en) Vaginal application mifepristone
AU1963395A (en) Boom-structure
AU2634695A (en) Hull-related arrangement
AU3794695A (en) Waveguide-coaxial converter
AU4029295A (en) Thienopyridones
AU1865797A (en) Printing tampon
AU4604397A (en) (o-acyl-p-n-acylamino-phenyl)-o-phosphoethanolamines
AU3166195A (en) Acylimidazopyridines
AU3666795A (en) Macerator
AU3166095A (en) Benzylimidazopyridines
AUPO168996A0 (en) Structure
AU3446995A (en) Biodestumping
AU2411395A (en) Hydrocopter
AU1603595A (en) Meso-azanoradamantanes